PREVENTION OF TYPE 2 DIABETES AT NATIONAL LEVEL

Size: px
Start display at page:

Download "PREVENTION OF TYPE 2 DIABETES AT NATIONAL LEVEL"

Transcription

1 PREVENTION OF TYPE 2 DIABETES AT NATIONAL LEVEL Jaana Lindström PhD, Adjunct professor, Head of Unit Diabetes Prevention Unit Department of Chronic Diseases Prevention National Institute for Health and Welfare Helsinki, Finland

2 Outline OUTLINE: Epidemiology Prevention of type 2 diabetes: clinical evidence Identification of high-risk individuals National diabetes prevention programme in Finland 2

3 WHO 1999 criteria and ADA 2003 criteria Plasma venous glucose concentration, mmol/l ADA 2010 Diabetes: +HbA1c >6.5% Pre-diabetes: +HbA1c % 3

4 Type 2 diabetes* in Finland Women Men Total *data based on drug reimbursement and hospital registers Source: Sund et al: FinnDM II 4

5 Finrisk 1987 Finrisk 1992 Health 2000 Finrisk 2002 D2D 2004 Number of diabetics Prevalence in population surveys, % Epidemiology: Diabetes trends in Finland Drug register Population surveys Total estimate 0 Puska et.al. Yleislääkärilehti 2008;2:11-3 5

6 Disturbances in glucose metabolism in Finns aged y. FIN-D2D survey 2004 (n=2896) Men Women Diagnosed type 2 diabetes 7.4% 4.3% } 15.7% Screen-detected type 2 diabetes 8.3% 6.9% Impaired glucose tolerance 14.7% 15.9% Impaired fasting glucose 9.3% 4.8% Total*: 41.8% 33.2% } 11.2% Peltonen et. Al. Suom Lääkäril 2006;61:

7 Cost of diabetes treatment in 2007 Type 2 diabetes without complications eur Type 2 diabetes with complications eur In the long run, the costs related to loss of productivity due to diabetes (e.g. cost of early retirement) are 1,5x medical costs Source: Jarvala et al. Diabeteksen kustannukset Suomessa tutkimus, Dehko. 7

8 Outline Epidemiology Prevention of type 2 diabetes: clinical evidence Identification of high-risk individuals National diabetes prevention programme in Finland 8

9 Risk factors for type 2 diabetes Paulweber et al. Horm Metab Res 2010;42(Suppl 1): S3-S36 9

10 Body mass index and type 2 diabetes risk RR < x x >= RR < x x >=35.0 MEN Chan et al. Diabetes Care 1994; 17:961-9 WOMEN Colditz et al. Ann Intern Med 1995; 122:

11 Body mass index and prevalence of diabetes Prevalence, % Prevalence, % D2D-health survey Agegroup year Diagnosed diabetes Men Women < Body mass index Screen-detected diabetes Men Women < Body mass index Saaristo et al. BMC Public Health 2008;8:

12 BMI among year old men and women in Finland MEN WOMEN Pohjois-Karjala Pohjois-Savo 28 Turku/Loimaa Helsinki/Vantaa 27 Oulun lääni Lapin lääni 26 Pohjois-Karjala Pohjois-Savo Turku/Loimaa Helsinki/Vantaa Oulun lääni Lapin lääni Year : 70% of men were overweight BMI % 2007: BMI % BMI >30 19% BMI >30 21% 12

13 Obesity trends in adults

14 The Finnish Diabetes Prevention Study (DPS) The main aim: to determine whether lifestyle intervention of overweight, middle-aged men and women with impaired glucose tolerance (IGT) will prevent or delay the development of type 2 diabetes Individually randomized, controlled, multicenter trial 522 participants randomly allocated into intensive diet and physical activity intervention or control (standard) treatment Annual clinical and laboratory examination N Engl J Med 2001; 344:

15 DPS intervention goals: Weight reduction > 5% Fat intake < 30 % of total energy Saturated fat intake < 10 E% Fiber intake > 15 g/1000 kcal Aerobic and muscle strengthening exercise >30 min/day Lindström et al. Diabetes Care 2003; 26:

16 DPS lifestyle intervention: INTERVENTION GROUP: 7 dietary counselling sessions during the first year, and every 3 months thereafter Individually tailored diet based on 3-day food diaries Free-of-charge gym, individually designed exercise programme CONTROL GROUP: General advice about healthy diet and exercise habits No individualized counselling Lindström et al. Diabetes Care 2003; 26:

17 Cumulative incidence of diabetes DPS: Diabetes incidence was 58% lower among the intervention group compared with the control group after mean follow-up of 3,2 years HR Weight reduction > 5% Moderate fat <30 E% Low saturated fat <10 E% High fibre >15g/1000kcal Physical activity >30 min / day N Engl J Med 2001; 344:

18 DPS: Diabetes incidence was 43% lower among the intervention group compared with the control group after median follow-up of 7 years HR Intervention ceased Weight reduction > 5% Moderate fat <30 E% Low saturated fat <10 E% High fibre >15g/1000kcal Physical activity >30 min / day Lancet 2006; 368:

19 Incidence per 100 person years The DPS: The more goals achieved, the lower the risk! HR Number of goals achieved Weight reduction > 5% Moderate fat <30 E% Low saturated fat <10 E% High fibre >15g/1000kcal Physical activity >30 min /day Goals at year 3; incidence during 7 years follow-up 19

20 Prevention of type 2 diabetes by lifestyle intervention the evidence Study Intervention N Drop-out rate FU time Risk reduction Ref The Da-Qing Study China Diet Exercise Diet+exercise Control % 6 years 31% 46% 42% Pan et al Diabetes Care 20: The DPS Finland Diet+physical activity Control % 3,2 years 58% Tuomilehto et al new Engl J Med The DPP USA Diet+physical activity Metformin Placebo % 2,8 years 58% 31% DPP research group New Engl J Med 346: IDDP India Lifestyle Metformin Lifestyle+metformin Control % 30 months 28,5% 26,4% 28,2% Ramachandran et al Diabetologia 49: Japanese trial on IGT males Japan Diet+exercise Control % 4 years 67,4% Kosaka et al Diabetes Res Clin Pract 67: The SLIM Study The Netherlands Diet+physical activity Control % 3 years 58% Roumen et al Diabetic Medicine 25: EDIPS Newcastle UK Diet+physical activity Control % 3,1 years 55% Penn et al BMC Public Health 9 PREDIMED-Reus Spain Diet Control % 4 years 52% Salas-Salvado et al Diabetes Care 20

21 Meta-analysis of effect of lifestyle interventions on risk of developing type 2 diabetes NNT to prevent one case of diabetes = 6.4 (over years) Gillies et al BMJ 334:299-21

22 Outline Epidemiology Prevention of type 2 diabetes: clinical evidence Identification of high-risk individuals National diabetes prevention programme in Finland 22

23 The Finnish Diabetes Risc Score - FINDRISC AIM: To develop a simple, cheap and reliable way to identify people at high risk of type 2 diabetes in the general population which does not require: blood drawing other measurements by trained personnel medical equipment Lindström et al. Diabetes Care 2003;26:

24 FINDRISC: Risk model development: FINRISK-87 SURVEY Excluded if: - age < 35 yrs. - DM medication - missing variables 10 years follow-up (drug register) 182 T2D cases identified 4435 subjects with baseline data Validation cohort: FINRISK-92 SURVEY Excluded if - age < 35 yrs. - DM medication - missing variables 4586 subjects with baseline data 5 years follow-up (drug register) 67 T2D cases identified Lindström et al. Diabetes Care 2003;26:

25 Type 2 Diabetes Risk Score - FINDRISC: Age BMI Waist Physical activity Nutrition (f+v) Hypertension Hyperglycaemia Family history Lindström et al. Diabetes Care 2003;26:

26 DPS: Diabetes in the intervention vs. control group by baseline FINDRISC Incidence rate per 100 person-years % NNT= 3.6 NNT= 8.3 All FINDRISC Control Intervention Diabetes Care 2008; 31:

27 FINDRISC is used also outside of Finland FINDRISC modified FINDRISC 27

28 Outline Epidemiology Prevention of type 2 diabetes: clinical evidence Identification of high-risk individuals National diabetes prevention programme in Finland 28

29 NATIONAL DIABETES PROGRAMME: DEHKO Coordinator: The Finnish Diabetes Association Researchers Experts Clinicians Other professionals People with diabetes 1) Prevention of type 2 diabetes 2) Improving the quality of diabetes care 3) Support for self-care 29

30 Development Programme for the Prevention and Care of Diabetes in Finland: DEHKO Programme for the Prevention of Type 2 Diabetes in Finland Three strategies: Population strategy High risk strategy Early diagnosis and treatment strategy 30

31 Development Programme for the Prevention and Care of Diabetes in Finland: DEHKO Programme for the Prevention of type 2 Diabetes in Finland Pilot project FIN-D2D

32 FIN-D2D: Participating hospital districts Total population of Finland: ~5,2 million 20 hospital districts; 348 municpalities 5 hospital districts chose to participate in FIN-D2D: ~110 health centres in municipalities ~110 municipal occupational health care providers ~100 private occupational health care providers Target population ~1,5 million 32

33 FIN-D2D: Main aims Clarify the feasibility of a diabetes prevention programme based on the experiences from the Finnish Diabetes Prevention Study DPS within primary health care in Finland Make screening, diagnosis and interventions part of every-day work of primary health care Create new models and practices for prevention of diabetes and obesity Increase awareness of the risks of obesity and diabetes 33

34 FIN-D2D partners: Finnish Diabetes Association National Public Health Institute The 5 hospital districts Funding: Municipalities in hospital districts Ministry of Social Affairs and Health Finland s Slot Machine Association Finnish Diabetes Association National Public Health Institute External research grants 34

35 FIN-D2D: High-risk strategy Screening, diagnosis and interventions: The Finnish Diabetes Risk Score FINDRISC CHD Gestational diabetes IFG/IGT Score < 7 Score 7-14 No preventive measures Written information Score 15 2h OGTT Diabetes Normoglycemia IFG IGT Treatment of hyperglycemia and risk factors INTERVENTIONS FOLLOW-UP 35

36 FIN-D2D Project: Interventions Primary health care or other players: Weight control groups Quit smoking-groups Exercise groups Self-activity groups Group intervention Identification of high-risk subject 1. Visit (nurse) 2. Visit (doctor) Individual intervention Yearly follow-ups Self-initiated lifestyle changes Other Intervention forms Regular healthcare visits 36

37 FIN-D2D: Positive experiences Nationwide recognition and icreased awareness of obesity and diabetes problem Models of lifestyle intervention are possible to implement in primary health care people with moderate or high diabetes risk identified and participated interventions within primary health care Screening and risk assessment part of daily practice: The FINDRISC OGTT testing increased x3 Waist circumference measurement Treatment paths built Collaboration Hospital districts, municipalities, health care centers, occupational health care, NGOs, pharmacies, research organizations Multi-professional team work International influence (DE-PLAN, IMAGE etc) 37

38 Visits and FINDRISC completers years visits/month ~10% of the population have done the FINDRISC Käynnit Visits sivulla Riskitestin FINDRISC täyttö Joulukuu

39 Transition from disease-based prevention to health promotion in wider scope Health promotion units were establised in all participating hospital districts Prevention was recognized important (however not in all levels ) Health in All Policies 39

40 FIN-D2D: Challenges Primary care information technology: several different systems; difficulties to monitor people Preventive work in health care as projects (requires coordination, now often competion of already scarce resources) How to get physicians involved in primary preventive work? Questionnaires to assess person s need and motivation for lifestyle change are too complicated How to get men involved in the interventions? How to get different socioeconomic groups activated? What to do with high-risk persons who do not participate in these sorts of programmes? How many are they? 40

41 FIN-D2D: High-risk individuals >10,000 high risk persons included in interventions in primary and occupational health care by the end of year Additional 9,900 persons with risk score 7-14 have received written information. More than 20,000 have contacted primary or occupational health care system due to programme. 41

42 D2D high-risk cohort n= (women 67 %) Intervention No follow-up n= (45,6 %) Follow-up information n= (54,4 %) Follow-up within 9-18 months n= No baseline OGTT n= diabetes n= year follow-up n=2 798 Suom Lääkäril /

43 D2D: Lifestyle intervention results Majority of the D2D high-risk participants chose individual lifestyle counselling instead of group counselling No strong tradition for group activities (neither among caregivers nor clients) Would require changes in models of care, e.g. invitations based on patient register search Mean number of intervention visits was 2,9 Mean 1-year weight reduction was 1,2 kg (in the DPS 4,5 kg) 17% lost more than 5% 43

44 D2D: 1-year weight change by number of intervention visits Weight change Increased >2,5% No change Reduced 2,4-4,9% Reduced <5% Number of visits Suomen Lääkärilehti 26-31,

45 Diabeteksen ilmaantuvuus (%) D2D: 1-year diabetes incidence* and relative risk by weight change 8 7 Ref +10 % RR % % 1 0 >5% lasku 2,5-4,9% lasku Ei muutosta >2,5% nousu *Age-adjusted Diabetes Care 2010; 33:

46 Population level evaluation FINRISK 2002 Northern Karelia Kainuu Turku-Loimaa Helsinki-Vantaa Northern Savo Northern Ostrobothnia FINRISK 2007 Northern Karelia Kainuu Turku-Loimaa Helsinki-Vantaa Northern Savo Northern Ostrobothnia N=2039 N=919 N=2255 N=1295 South Ostrobothnia Northern Ostrobothnia Northern Savo Central Finland Kainuu Northern Karelia FIN-D2D 2004 South Ostrobothnia Central Finland Pirkanmaa N=2896 FIN-D2D 2007 South Ostrobothnia Central Finland Pirkanmaa N=2868 Pirkanmaa Turku, Loimaa Helsinki, Vantaa Year Salopuro T ym. unpublished 46

47 D2D: Findings on the national level Half of all diabetes cases in the age group are unidentified Obesity trend in Finland seems to leveling off 47

48 Future challenges The diabetes epidemic prevails How to continue the work started by DEHKO? Who is in charge? Children and adolescents? The work has only started 48

49 European evidence-based guideline for the prevention of type 2 diabetes Toolkit for the prevention of type 2 diabetes Quality and outcome indicators for prevention of type 2 diabetes 49

Implementing Type 2 Diabetes Prevention Programmes

Implementing Type 2 Diabetes Prevention Programmes Implementing Type 2 Diabetes Prevention Programmes Jaakko Tuomilehto Department of Public Health University of Helsinki Helsinki, Finland FIN-D2D Survey 2004 Prevalence of previously diagnosed and screen-detected

More information

Pre-diabetes. Dr Neel Basudev. GPSI Lambeth DICT, Diabetes Lead Lambeth CCG

Pre-diabetes. Dr Neel Basudev. GPSI Lambeth DICT, Diabetes Lead Lambeth CCG Pre-diabetes Dr Neel Basudev GPSI Lambeth DICT, Diabetes Lead Lambeth CCG The Prevention of Diabetes Where has this come from? Pre-diabetes mellitus (PDM) Term introduced by Tommy G. Thompson (Health &

More information

How to strengthen the global evidence base for effective prevention of diabetes and its complications?

How to strengthen the global evidence base for effective prevention of diabetes and its complications? How to strengthen the global evidence base for effective prevention of diabetes and its complications? Brian Oldenburg Professor of International Public Health Monash University AUSTRALIA brian.oldenburg@monash.edu

More information

WCPD10 Edinburgh 15 th 18 th July Pirjo Ilanne-Parikka

WCPD10 Edinburgh 15 th 18 th July Pirjo Ilanne-Parikka WCPD10 Edinburgh 15 th 18 th July 2018 Pirjo Ilanne-Parikka Pirjo Ilanne-Parikka MD, PhD, Diabetologist Physician in Chief, Finnish Diabetes Association Project manager, Diabeteshub, Health Village in

More information

Primary Prevention of T2DM. KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009

Primary Prevention of T2DM. KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009 Primary Prevention of T2DM KW Chan Endocrine & Diabetes Team Department of M&G, PMH 22 March 2009 Primary Prevention of T2DM Why to intervene? When to intervene? Lifestyle intervention Pharmacological

More information

programme. The DE-PLAN follow up.

programme. The DE-PLAN follow up. What are the long term results and determinants of outcomes in primary health care diabetes prevention programme. The DE-PLAN follow up. Aleksandra Gilis-Januszewska, Noël C Barengo, Jaana Lindström, Ewa

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

International model for prevention of chronic disease: Finland experience

International model for prevention of chronic disease: Finland experience International model for prevention of chronic disease: Finland experience Erkki Vartiainen, MD, Professor, Assistant Director General 06/12/2011 Erkki Vartiainen 1 2 Start of the North Karelia project

More information

Community Based Diabetes Prevention

Community Based Diabetes Prevention Community Based Diabetes Prevention Melanie Davies Professor of Diabetes Medicine Outline NIHR Programme Grant proposal and update to progress The Vascular Check programme HbA1c debate Algorithm to detect

More information

Results of the North Karelia Project and national NCD prevention

Results of the North Karelia Project and national NCD prevention Results of the North Karelia Project and national NCD prevention Erkki Vartiainen, MD, Professor, Assistant Director General 28/03/2011 Erkki Vartiainen 1 2 Start of the North Karelia project (1) Seven

More information

News & Views. The future of diabetes prevention: a focus on the implications of the Diabetes Prevention Program Outcomes Study. News.

News & Views. The future of diabetes prevention: a focus on the implications of the Diabetes Prevention Program Outcomes Study. News. The future of diabetes prevention: a focus on the implications of the Diabetes Prevention Program Outcomes Study Tania Acosta1,2,3: Tania Acosta Vergara is physician at the free University of Barranquilla

More information

Type 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018

Type 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018 Type 2 diabetes how to prevent it? East of England Diabetes Mellitus Transformation and Sustainability Network 28 th March 2018 Dr Charles Bodmer Consultant Clinical Lead Dr Sonica Goel GP Clinical Lead

More information

Jaakko Tuomilehto. MD, MA, PhD, FRCP(Edin), FESC

Jaakko Tuomilehto. MD, MA, PhD, FRCP(Edin), FESC Políticas en diabetes para la prevención y manejo de la enfermedad cardiovascular. Nueva directiva Europea 2013 Jaakko Tuomilehto MD, MA, PhD, FRCP(Edin), FESC Department of Chronic Disease Prevention,

More information

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Presented in Collaboration with New Mexico Health Care Takes On Diabetes Discuss the burden and challenges prediabetes presents in New Mexico.

More information

Prevention of type 2 diabetes: Reviewing mechanisms of successful interventions and translation of major trial evidence to practice.

Prevention of type 2 diabetes: Reviewing mechanisms of successful interventions and translation of major trial evidence to practice. Public Health Collaborating Centre Prevention of type 2 diabetes: Reviewing mechanisms of successful interventions and translation of major trial evidence to practice. Prevention of progression to type

More information

Reducing the risk of type 2 diabetes with nutrition and physical activity efficacy and implementation of lifestyle interventions in Finland

Reducing the risk of type 2 diabetes with nutrition and physical activity efficacy and implementation of lifestyle interventions in Finland Public Health Nutrition: 13(6A), 993 999 doi:10.1017/s1368980010000960 Reducing the risk of type 2 diabetes with nutrition and physical activity efficacy and implementation of lifestyle interventions in

More information

FAMILY SUPPORT IS ASSOCIATED WITH SUCCESS IN ACHIEVING WEIGHT LOSS IN A GROUP LIFESTYLE INTERVENTION FOR DIABETES PREVENTION IN ARAB AMERICANS

FAMILY SUPPORT IS ASSOCIATED WITH SUCCESS IN ACHIEVING WEIGHT LOSS IN A GROUP LIFESTYLE INTERVENTION FOR DIABETES PREVENTION IN ARAB AMERICANS FAMILY SUPPORT IS ASSOCIATED WITH SUCCESS IN ACHIEVING WEIGHT LOSS IN A GROUP LIFESTYLE INTERVENTION FOR DIABETES PREVENTION IN ARAB AMERICANS Objective: We have recently shown the feasibility of a community-based,

More information

Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care

Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care One-year follow-up of the Finnish National

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Copyright 2017 by Sea Courses Inc.

Copyright 2017 by Sea Courses Inc. Pre-Diabetes: Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any means graphic, electronic, or mechanical,

More information

NCD MONITORING AND NPHI S

NCD MONITORING AND NPHI S Pekka Puska, Professor, MD, PhD, MPolSc Director General, National Institute for Health and Welfare (THL), Finland Vice President, International Association of National Public Health Institutes (IANPHI)

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

Diabetes is a condition with a huge health impact in Asia. More than half of all

Diabetes is a condition with a huge health impact in Asia. More than half of all Interventions to Change Health Behaviors and Prevention Rob M. van Dam, PhD Diabetes is a condition with a huge health impact in Asia. More than half of all people with diabetes live today in Asian countries,

More information

Presenter Disclosure Information

Presenter Disclosure Information Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES

COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES COMMUNITY EFFORTS TO PREVENT TYPE 2 DIABETES 15 th Population Health Colloquium March 23, 2015 Marti Macchi, MEd., MPH Senior Consultant National Association of Chronic Disease Directors Today s Agenda

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

National type 2 diabetes prevention programme in Finland: FIN-D2D

National type 2 diabetes prevention programme in Finland: FIN-D2D International Journal of Circumpolar Health ISSN: (Print) 2242-3982 (Online) Journal homepage: http://www.tandfonline.com/loi/zich20 National type 2 diabetes prevention programme in Finland: FIN-D2D Timo

More information

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be

More information

Strategies for the prevention of type 2 diabetes and cardiovascular disease

Strategies for the prevention of type 2 diabetes and cardiovascular disease European Heart Journal Supplements (2005) 7 (Supplement D), D18 D22 doi:10.1093/eurheartj/sui025 Strategies for the prevention of type 2 diabetes and cardiovascular disease Jaakko Tuomilehto 1,2,3 *, Jaana

More information

Why Do We Care About Prediabetes?

Why Do We Care About Prediabetes? Why Do We Care About Prediabetes? Complications of Diabetes Diabetic Retinopathy Leading cause of blindness in adults 1,2 Diabetic Nephropathy Leading cause of Kidney failure Stroke 2- to 4-fold increase

More information

Nutrition policy in Finland

Nutrition policy in Finland Nutrition policy in Finland Suvi M. Virtanen, Professor 13.3.2012 20/03/2012 Nutrition policy in Finland / SM Virtanen 1 The top of Europe Four seasons Population 5,4 million Life expectancy at birth:

More information

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children

It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children It s Never Too Early To Prevent Diabetes: The Lasting Impact of Gestational Diabetes on Mothers and Children Robert Ratner, M.D., F.A.C.P. Vice President for Scientific Affairs, Medstar Research Institute

More information

J. Michael Gonzalez-Campoy, MD, PhD, FACE Teresa Pearson, MS, RN, CDE, FAADE

J. Michael Gonzalez-Campoy, MD, PhD, FACE Teresa Pearson, MS, RN, CDE, FAADE SCREEN, COUNSEL, REFER AND FOLLOW-UP FOR DIABETES AND PREDIABETES J. Michael Gonzalez-Campoy, MD, PhD, FACE drmike@mncome.com Teresa Pearson, MS, RN, CDE, FAADE tpearson@hallelandhabicht.net Sponsored

More information

ACHIEVEMENTS AND CHALLENGES IN NCD PREVENTION IN FINLAND

ACHIEVEMENTS AND CHALLENGES IN NCD PREVENTION IN FINLAND Pekka Puska Professor, Member of Parliament Past Director General, National Institute for Health and Welfare (THL), Finland Past President, International Association of National Public Health Institutes

More information

The Diabetes Prevention Program: Call for Action

The Diabetes Prevention Program: Call for Action The Diabetes Prevention Program: Call for Action Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Harvard Medical

More information

Tackling Type 2 Diabetes in the US: Translating Science into Public Policies and Actions

Tackling Type 2 Diabetes in the US: Translating Science into Public Policies and Actions Tackling Type 2 Diabetes in the US: Translating Science into Public Policies and Actions Edward Gregg, PhD Division of Diabetes Translation Centers for Disease Control and Prevention Atlanta, GA The findings

More information

Diabetes Mellitus Aeromedical Considerations. Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013

Diabetes Mellitus Aeromedical Considerations. Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013 Diabetes Mellitus Aeromedical Considerations Aviation Medicine Seminar Bucharest, Romania. 11 th to 15 th November 2013 Metabolic, Nutritional or Endocrine disorders Applicants with metabolic, nutritional

More information

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study Jaana Lindström, Pirjo Ilanne-Parikka, Markku Peltonen, Sirkka Aunola,

More information

Newbury Pre Diabetes Project

Newbury Pre Diabetes Project Newbury and District CCG Newbury Pre Diabetes Project A real-world implementation of QDiabetes in a CCG Area Tim Walter Aims of the PreDM Project Raise awareness generally Lifestyle intervention for those

More information

Dehko Proceeds

Dehko Proceeds Dehko Proceeds 2005 2007 2 Development Programme for the Prevention and Care of Diabetes DEHKO 2000 2010 Primary Prevention of Type 2 Diabetes Developing Diabetes Care and its Quality Supporting Self-Care

More information

Pre-diabetes: Information for primary care practitioners

Pre-diabetes: Information for primary care practitioners Pre-diabetes: Information for primary care practitioners Michelle Barker 2005 Important Messages This booklet is based on three key messages for patients. 1. Pre-diabetes is a serious condition with a

More information

Precision Health Economics, Not Just Genetics

Precision Health Economics, Not Just Genetics Precision Health Economics, Not Just Genetics The Impact of Real-World User Behavior and Treatment Adherence Patterns on Health and Economic Outcomes Janne Martikainen Professor (pharmacoeconomics) Deputy

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR.

Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR. Early determinants of cardiovascular, metabolic and reproductive health --- EDCaR. Harri Niinikoski MD, PhD, Pediatric endocrinologist Professor of Nutrition in Medicine University of Turku/Physiology

More information

Overweight is defined as a body mass

Overweight is defined as a body mass THE DANGEROUS LIAISON: WEIGHT GAIN AND ITS ASSOCIATED COMORBIDITIES * Zachary T. Bloomgarden, MD ABSTRACT Overweight and obesity have tangible physical consequences that affect mortality and economics,

More information

Introduction to Finnish NCD Prevention. PREVENTION OF NONCOMMUNICABLE DISEASES SEMINAR, Helsinki

Introduction to Finnish NCD Prevention. PREVENTION OF NONCOMMUNICABLE DISEASES SEMINAR, Helsinki Introduction to Finnish NCD Prevention PREVENTION OF NONCOMMUNICABLE DISEASES SEMINAR, Helsinki 14.3.2011 28/03/2011 Pekka Puska, Director General 2 Global Health Burden Estimated global deaths by cause,

More information

Prevention of diabetes in the modern era of affluent society and economic constraints

Prevention of diabetes in the modern era of affluent society and economic constraints Prevention of diabetes in the modern era of affluent society and economic constraints KONSTANTINOS MAKRILAKIS, MD, MPH, PhD ASSOCIATE PROFESSOR IN INTERNAL MEDICINE NATIONAL AND KAPODISTRIAN UNIVERSITY

More information

Lifestyle Counseling for Type 2 Diabetes Risk Reduction in Dutch Primary Care. Results of the APHRODITE study after 0.5 and 1.

Lifestyle Counseling for Type 2 Diabetes Risk Reduction in Dutch Primary Care. Results of the APHRODITE study after 0.5 and 1. Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Lifestyle Counseling for Type 2 Diabetes Risk Reduction in Dutch Primary Care Results of the APHRODITE study after

More information

Screening and Diagnosis of Diabetes Mellitus in Taiwan

Screening and Diagnosis of Diabetes Mellitus in Taiwan Screening and Diagnosis of Diabetes Mellitus in Taiwan Hung-Yuan Li, MD, MMSc, PhD Attending Physician, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Associate Professor,

More information

STATE OF THE STATE: TYPE II DIABETES

STATE OF THE STATE: TYPE II DIABETES STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES

More information

Glycemic control in type 2 diabetes. Exercise prescription in type 2 diabetes treatment. Target for diabetes intervention.

Glycemic control in type 2 diabetes. Exercise prescription in type 2 diabetes treatment. Target for diabetes intervention. Exercise prescription in type 2 diabetes treatment Glycemic control in type 2 diabetes Prof. L.J.C. van Loon The level of glycemia is associated with the development of cardiovascular complications Glycemic

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

The Finnish Diabetes Prevention Study

The Finnish Diabetes Prevention Study British Journal of Nutrition (2000), 83, Suppl. 1, S137 S142 S137 The Finnish Diabetes Prevention Study Matti Uusitupa 1 *, Anne Louheranta 2, Jaana Lindström 2, Timo Valle 2, Jouko Sundvall 2, Johan Eriksson

More information

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study

Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study Diabetes Care Publish Ahead of Print, published online February 5, 2008 Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study Jaana Lindström, PhD 1, 2,

More information

Prediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD

Prediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD Prediabetes & Type 2 Diabetes Prevention Jacob M. Haus, PHD Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants:

More information

Diabetes Treatment Update

Diabetes Treatment Update Diabetes Treatment Update Timothy C. Evans, MD PhD FACP University of Washington Department of Medicine Disclosure: Dr. Evans has no significant financial interest in any of the products or manufacturers

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives Margo N. Woods, D.Sc. 1. Discuss the increase in the incidence and prevalence of type

More information

Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS

Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS Prediabetes: Metformin vs. Lifestyle Intervention Tannaz Moin, MD, MBA, MSHS Assistant Professor, David Geffen School of Medicine at UCLA Division of Endocrinology, Diabetes and Metabolism HSR&D Center

More information

Obesity Prevention and Control: Provider Education with Patient Intervention

Obesity Prevention and Control: Provider Education with Patient Intervention Obesity Prevention and : Provider Education with Patient Summary Evidence Table and Population Cohen et al. (1991) 1987-1988 : RCT Location: Pittsburgh, PA Physician training session by a behavioral psychologist

More information

GPSF Annual Conference 2018 Non Communicable Diseases: An Overview Of The Twin Epidemics of Diabetes and Obesity - Diabesity

GPSF Annual Conference 2018 Non Communicable Diseases: An Overview Of The Twin Epidemics of Diabetes and Obesity - Diabesity GPSF Annual Conference 2018 Non Communicable Diseases: An Overview Of The Twin Epidemics of Diabetes and Obesity - Diabesity Kwabena O.M. Adubofour, MD, FWACP, FACP Medical Director, East Main Clinic and

More information

Randomized controlled trials with

Randomized controlled trials with Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Determinants for the Effectiveness of Lifestyle Intervention in the Finnish Diabetes Prevention Study JAANA LINDSTRÖM,

More information

Quality and Outcome Indicators for Prevention of Type 2 Diabetes in Europe IMAGE

Quality and Outcome Indicators for Prevention of Type 2 Diabetes in Europe IMAGE Pia Pajunen, Rüdiger Landgraf, Frederik Muylle, Anne Neumann, Jaana Lindström, Peter Schwarz, Markku Peltonen Quality and Outcome Indicators for Prevention of Type 2 Diabetes in Europe IMAGE IMAGE stands

More information

For peer review only. BMJ Open. For peer review only -

For peer review only. BMJ Open. For peer review only - Increasing physical activity is associated with improved cardio-metabolic risk profile during lifestyle intervention in primary healthcare among individuals at high risk for type diabetes: the Finnish

More information

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014

Gestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014 Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome

More information

Response to reviewer comments

Response to reviewer comments Response to reviewer comments Reviewer Comment BMJ Does it make sense, though, to provide an overall sensitivity and specificity? There must be subpopulations of interest and we worry that these overall

More information

Prediabetes Prevalence and Risk Factors in Alabama, 2013

Prediabetes Prevalence and Risk Factors in Alabama, 2013 Prediabetes Prevalence and Risk Factors in Alabama, 2013 Emily Piercefield, MD, MPH CDC Assignee to the Alabama Department of Public Health Bureau of Health Promotion and Chronic Disease CSTE June 15,

More information

Karri Silventoinen University of Helsinki and Osaka University

Karri Silventoinen University of Helsinki and Osaka University Karri Silventoinen University of Helsinki and Osaka University Childhood is an important phase of life and creates the base for all further life Childhood is the time of rapid physiological development

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Obesity in Finland activity to prevent adverse trends

Obesity in Finland activity to prevent adverse trends Obesity in Finland activity to prevent adverse trends Marjaana Lahti-Koski development manager, health promotion Adjunct prof, PhD, MSc (nutrition), Finnish Heart Association marjaana.lahti-koski@sydanliitto.fi

More information

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS

IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS IMPROVED DIAGNOSIS OF TYPE 2 DIABETES AND TAILORING MEDICATIONS Dr Bidhu Mohapatra, MBBS, MD, FRACP Consultant Physician Endocrinology and General Medicine Introduction 382 million people affected by diabetes

More information

Trends In CVD, Related Risk Factors, Prevention and Control In China

Trends In CVD, Related Risk Factors, Prevention and Control In China Trends In CVD, Related Risk Factors, Prevention and Control In China Youfa Wang, MD, MS, PhD Associate Professor Center for Human Nutrition Department of International Health Department of Epidemiology

More information

Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre

Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus. Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre Initiating Insulin in Primary Care for Type 2 Diabetes Mellitus Dr Manish Khanolkar, Diabetologist, Auckland Diabetes Centre Outline How big is the problem? Natural progression of type 2 diabetes What

More information

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN

The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 1. INTRODUCTION The DIABETES CHALLENGE IN PAKISTAN FIFTH NATIONAL ACTION PLAN 2014 2018 UNITE AGAINST DIABETES STOP RISING TREND Diabetes is a significant and growing challenge globally that affects individuals,

More information

Diabetes and Weight Management: Tools to Affect Patient Outcomes

Diabetes and Weight Management: Tools to Affect Patient Outcomes Diabetes and Weight Management: Tools to Affect Patient Outcomes Today s discussion Review the problem of diabetes and the importance of lifestyle intervention Identify current research supporting the

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

Network of memory expert and support centres provides information and guidance in Finland

Network of memory expert and support centres provides information and guidance in Finland Network of memory expert and support centres provides information and guidance in Finland AE conference 11.10.2013 St Julians, Malta Specialist, Krista Pajala Alzheimer Society of Finland Alzheimer Society

More information

Energy Balance Equation

Energy Balance Equation Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT

More information

Promotion of physical activity in Finland

Promotion of physical activity in Finland Promotion of physical activity in Finland Katja Borodulin, Senior Researcher, Adj.Prof. 21.3.2012 1 Causal chain for ischaemic heart disease WHO: Global Health Risks Report, 2009 21.3.2012 2 Risk of impaired

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

The Effectiveness of Different Health Education Strategies in People with Pre-diabetes: A Randomized Controlled Trial

The Effectiveness of Different Health Education Strategies in People with Pre-diabetes: A Randomized Controlled Trial Journal of Health Science 2016, 6(2): 22-29 DOI: 10.5923/j.health.20160602.02 The Effectiveness of Different Health Education Strategies in People with Pre-diabetes: A Randomized Controlled Trial Shu-Chuan

More information

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women (Lancet. 2017 Mar 25;389(10075):1229-1237) 1 Silvia STRINGHINI Senior

More information

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y

Preventing Diabetes K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y Preventing Diabetes 2018 K A R O L E. W A T S O N, M D, P H D, F A C C P R O F E S S O R O F M E D I C I N E / C A R D I O L O G Y D A V I D G E F F E N S C H O O L O F M E D I C I N E A T U C L A CO-DIRECTOR,

More information

MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? References:

MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? References: MTE 4 and 9 Macronutrient Mix: Ideal Intake vs. Real-World Eating? Bayview Room, Bay Level Marion J. Franz, MS, RDN, CDE Saturday, March 5, 2016 2:00 p.m. 3:30 p.m. and 3:45 p.m. 5:15 p.m. Research trials

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background

Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence

More information

EuroPrevent 2010 Fatal versus total events in risk assessment models

EuroPrevent 2010 Fatal versus total events in risk assessment models EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the

More information

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV GUY DE BACKER Ghent University,Belgium ESC Congress 2012, aug.25-29th, Munich, Germany ESC Congress 2012, aug.25-29th, Munich,

More information

Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among People at Increased Risk

Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among People at Increased Risk Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among People at Increased Risk Study Characteristics Randomized Controlled Trials (Adults) Exclusion Ackermann 2008 18779029

More information

Type 2 Diabetes Mellitus 2011

Type 2 Diabetes Mellitus 2011 2011 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetes Mellitus Diagnosis 2011 Diabetes Mellitus Fasting Glucose

More information

Fasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study

Fasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study Fasting Glucose, Obesity, and Metabolic Syndrome as Predictors of Type 2 Diabetes: The Cooper Center Longitudinal Study Laura F. DeFina, MD,* Gloria Lena Vega, PhD,Þ David Leonard, PhD,Þ and Scott M. Grundy,

More information

Utilizing Computer Technology & Data Analytics in Supporting Patients in the Community:

Utilizing Computer Technology & Data Analytics in Supporting Patients in the Community: Utilizing Computer Technology & Data Analytics in Supporting Patients in the Community: A Chronic Disease Management Model to empower patients with Diabetes Mellitus Patty Kwong 16 Oct 2014 Introduction

More information

The effects of Aerobic Exercise vs. Progressive Resisted Exercise on body composition in obese children Dr.U.Ganapathy Sankar, Ph.

The effects of Aerobic Exercise vs. Progressive Resisted Exercise on body composition in obese children Dr.U.Ganapathy Sankar, Ph. The effects of Aerobic Exercise vs. Progressive Resisted Exercise on body composition in obese children Dr.U.Ganapathy Sankar, Ph.D Dean I/C, SRM College of Occupational Therapy, SRMUniversity, Kattankulathur,

More information

Prevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary Health Care in Bahrain

Prevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary Health Care in Bahrain Prevalence of Diabetes Mellitus among Non-Bahraini Workers Page 1 of 10 Bahrain Medical Bulletin, Vol.25, No.1, March 2003 Prevalence of Diabetes Mellitus among Non-Bahraini Workers Registered in Primary

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research   ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Study on Prevalence of Pre-Diabetes in Urban Area of Mumbai and Its Association with Various

More information

Risk Factors for Heart Disease

Risk Factors for Heart Disease Developmental Perspectives on Health Disparities from Conception Through Adulthood Risk Factors for Heart Disease Philip Greenland, MD Harry W. Dingman Professor Chair, Department of Preventive Medicine

More information

CHAPTER II. Review of literature

CHAPTER II. Review of literature CHAPTER II Review of literature The purpose of review of literature is to discover what is already known and what others have attempted to find out. Therefore, an intensive review of literature has been

More information

Nutrition Counselling

Nutrition Counselling Nutrition Counselling Frieda Dähler Augustiny, Nutritional Counsellor Preventive Cardiology & Sports Medicine University Clinic of Cardiology Optimal Diet for Prevention of Coronary Heart Disease Diet

More information

Dr Emma Solomon and Zoe Clifford

Dr Emma Solomon and Zoe Clifford Evaluation of the Living Well, Taking Control Community-based Prevention and Management of Type 2 Diabetes Programme: a Study Protocol and Presentation of Preliminary Findings Dr Emma Solomon and Zoe Clifford

More information